Digital cognitive care – anytime, anywhere

Greater possibilities for earlier detection and better outcomes – from baseline measurements to action plans

A complete toolset for providers.
A better journey for patients and families.

From screening to monitoring, it’s an all-in-one, fully-digital solution to accelerate intervention, empower action, and elevate the standard of care – from any device, in any location.

3 minutes to check cognitive health

Establishing a baseline is the first step to understanding cognitive status. Accurately and efficiently check cognitive health and determine if further testing may be needed.

3 mins timer

FDA Class II Medical Device

15 minutes to assess cognition

Detect subtle signs of cognitive impairment, which may have association with dementias, including Alzheimer’s disease.

Fully reimbursable

Brain with chart

Generate evidence-based care plans in minutes

Build, document, and deliver plans to empower patients and their care teams to take action with confidence and compassion.

Fully reimbursable


Braincheck app with charts
Overlay image

Earlier is better.

Cognitive impairment is extremely common – early detection
is key to unlocking opportunities to preserve brain health.
With prevalence on the rise, it’s time for a better way.

A young doctor with a digital tablet device is explaining the benefits of neurocognitive evaluation to a patient in her clinical practice, emphasizing patient care

Digital tools for a new era in brain health

Our next-generation digital solutions promote proactive screening, detect early signs of decline, and enable care planning, equipping providers from primary care to specialists with a complete toolset to maximize the window of intervention and take action.

Better cognitive care starts here.

7 million +

Americans are currently unaware they have mild cognitive impairment

Up to %
of these patients could go on to develop Alzheimer’s or dementia without intervention
Up to %
of these patients could go on to develop Alzheimer’s or dementia without intervention

We’re closing the gap

We’re closing the gap

Up to 40%

of Alzheimer’s disease and related dementias may be preventable or delayed by addressing key risk factors 

Ready to get started?

A new, more accessible journey towards empowered and informed brain health awaits.

References

  1. BrainCheck Screen Validation. (2023). Accessible via BrainCheck.com.
  2. Ye S, Sun K, Huynh D, Phi HQ, Ko B, Huang B, Hosseini Ghomi R. A Computerized Cognitive Test Battery for Detection of Dementia and Mild Cognitive Impairment: Instrument Validation Study. JMIR Aging 2022;5(2):e36825 doi: 10.2196/36825
  3. Groppell S, Soto-Ruiz KM, Flores B, Dawkins W, Smith I, Eagleman DM, Katz Y. A Rapid, Mobile Neurocognitive Screening Test to Aid in Identifying Cognitive Impairment and Dementia (BrainCheck): Cohort Study JMIR Aging 2019;2(1):e12615. https://doi.org/10.2196/12615
  4. 2024 Alzheimer’s disease facts and figures. Alzheimers Dement. 2024 May;20(5):3708-3821. doi: 10.1002/alz.13809. Epub 2024 Apr 30. PMID: 38689398; PMCID: PMC11095490.
  5. Soeren Mattke et al, Expected and diagnosed rates of mild cognitive impairment and dementia in the U.S. Medicare population: observational analysis, Alzheimer’s Research & Therapy (2023). DOI: 10.1186/s13195-023-01272-z
  6. Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):413–446. https://doi.org/10.1016/S0140-6736(20)30367-6

Some feature availability determined by EHR integration.

Scroll to Top